2. I do think there is still merit in reporting the study, and the argument is rather that simulated (experience) formats based on natural sampling are better than normalised frequency descriptive formats. Normalised formats are still used to communicate test statistics to health professionals, despite a vast literature showing that people have difficulty solving problems presented in this way (e.g., calculating the PPV). Natural frequencies are a format that improve on normalised formats, based in part on the concept of natural sampling that underlies the experience-based presentation used here. It would therefore be relevant to compare experiencebased presentations to natural frequency descriptive formats. The authors could mention this in their discussion. However, I do emphasise that the formats need to be referred to correctly throughout the manuscript.
I have a few more minor comments:
The abstract does not list the mean absolute error (only the 95% CI). Please include this in the abstract to facilitate understanding of the results. Further, the metric for evaluating accuracy is not clear in the abstract. It is not mentioned until the Method. As such, the reader may be confused about lower values indicating better accuracy (typically results from these studies have been reported as percentage correct, higher=better).
Did the authors expect any differences across the three diagnostic test conditions (gold standard vs. low sensitivity vs. low specificity) or were these conditions only included for repeated tests for participants (e.g., to check the robustness of the effect across variations of the problem)?
The Figure needs a caption and should explain what the axis means (value == MAE) and the red line.
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GENERAL COMMENTS
General Although an interesting topic, I think manuscript currently lacks clarity and needs careful attention to make it suitable for publication. A key issue is that is not at all clear what information was provided to clinicians.
Abstract:
The design is not clear in the abstract -reading this alone I do not understand what you have done. I think the abstract needs to be completely re-written to convey what was done in the study and what was found. What is an "experience condition" and a numerical condition? What are the proportions in brackets? Are these the CI for the proportion of clinicians correctly judging PPV? Why have you not also included the actual proportion? These numbers still appear very low even for the "experience condition" -is that not also something to highlight? Why "posterior values" rather than the more commonly used "predictive values"?
Background
The background does not adequately introduce the topic and is difficult to follow. You say in the first paragraph what you are trying to look at and then repeat this in the last paragraph of the background, much of this information would be more appropriate in the methods. Avoid abbreviations such as OB-GYNs I don't think that our review (Whiting 2015) showed that probability of no disease given a negative test result is underestimated -you reference our review to back up this statement. We found "tendency to overestimation for both positive and negative test results. 1. The authors contrast simulated experience-based probabilities with a numerical format they refer to as natural frequencies. Natural frequencies have been confused in the literature with normalised frequencies, a descriptive format that is computationally more complex and is similar to conditional probability formats. Natural frequencies, are not normalised, meaning that the computation is simpler. In fact, some authors have suggested that natural frequencies facilitate understanding because they are the end product of experience-based sampling in that they present, as a description, the joint frequencies that result from a natural sampling process. As there was no detail in the present paper to confirm that the correct format that is mentioned was used in the study, I looked up the supplementary material from a previous publication by the authors that was cited within the present manuscript. Here, the format that has been used is normalised frequencies, not natural frequencies. I refer the authors to the publication by Gigerenzer and Hoffrage ( (1) with 1(3), the difference between the representation formats is shown. Importantly, natural frequencies are joint frequencies.
2. In light of this, I have two suggestions for the authors on how to frame the study: Change all mentions (and citations) of natural frequencies in the study to correctly identify them as normalised frequencies, and highlight that normalised frequencies are similar to conditional probability representations, but the numerical format is in frequencies. In the discussion somewhere, it would be important to mention that natural frequencies are an alternative numerical format that has been shown to enhance performance (see point below).
Response: We thank the reviewer for this important comment. We have corrected the terminology throughout the manuscript and we now mention previous research on natural frequencies in the introduction and discussion (p. 4,8,9) .
3. I do think there is still merit in reporting the study, and the argument is rather that simulated (experience) formats based on natural sampling are better than normalised frequency descriptive formats. Normalised formats are still used to communicate test statistics to health professionals, despite a vast literature showing that people have difficulty solving problems presented in this way (e.g., calculating the PPV). Natural frequencies are a format that improve on normalised formats, based in part on the concept of natural sampling that underlies the experience-based presentation used here. It would therefore be relevant to compare experience-based presentations to natural frequency descriptive formats. The authors could mention this in their discussion. However, I do emphasise that the formats need to be referred to correctly throughout the manuscript.
Response: In line with this suggestion, we now mention as a future direction the comparison of experience and natural frequency formats (p. 9).
4. The abstract does not list the mean absolute error (only the 95% CI). Please include this in the abstract to facilitate understanding of the results.
Response: The abstract now includes the mean absolute errors.
5. Further, the metric for evaluating accuracy is not clear in the abstract. It is not mentioned until the Method. As such, the reader may be confused about lower values indicating better accuracy (typically results from these studies have been reported as percentage correct, higher=better).
Response: We have added a description at the beginning of the results section of the abstract to clarify the metric for evaluating accuracy.
6. Did the authors expect any differences across the three diagnostic test conditions (gold standard vs. low sensitivity vs. low specificity) or were these conditions only included for repeated tests for participants (e.g., to check the robustness of the effect across variations of the problem)?
Response: We had no a priori hypotheses for differences among the tests. Rather, we included 3 tests to check the robustness of the format effect. We now say this explicitly in the paper (p. 5,6,8). Response: We have extensively revised the background section and moved some information to the method section, as suggested.
4. Avoid abbreviations such as OB-GYNs.
Response: We have removed the abbreviation.
5. I don't think that our review (Whiting 2015) showed that probability of no disease given a negative test result is underestimated -you reference our review to back up this statement. We found "tendency to overestimation for both positive and negative test results."
Response: We thank the reviewer for pointing out this error. We have corrected it, and we now refer to the overestimation of positive and negative predictive values (see abstract and p. 4).
6. I do not know what you mean by details such as prevalence, test sensitivity and specificity being communicated via leaflets. Also, I am not sure that it is true that "clinicians interpret test results on the basis the basis of relevant statistics such as disease prevalence, test sensitivity and test specificity." You make this statement but do not support it with a reference.
Response: We have removed the mention of leaflets. The example of numerical summaries being similar to leaflets (or in other words, a pamphlet) has been used in prior literature (see Gigerenzer, Gaissmaier, Kurz-Milcke, et al., 2007 Response: We have rewritten the method section to provide greater clarity on both formats. As mentioned, we have also provided a new figure (the new Figure 1 ) and an Appendix.
9. Looking at the results presented you have the "mean absolute error rate". This is not clearly described in the methods. Why have you chosen this rather than presenting something that would be much easier to understand such as the proportion of clinicians who correctly estimated PPV/NPV within say 5 or 10%? Or the difference in estimated and actual PPV/NPV? Or is that what you mean by the error rate?
Response: The mean absolute error refers to the difference in estimated and actual PPV and NPV.
We have now clarified this in the abstract and in the method section (ps. 2, and 7). Please also see our response to Reviewer 1, Comment 7.
10. Table 1 This is rather lacking in detail. Is there not any other information that would be helpful here?
We have removed the table that describes participant information, and have instead added it in-text at the beginning of the results section (p. 7). Please leave your comments for the authors below I consider this an interesting experiment and to my knowledge novel in its approach in using simulated patients as a form as fast paced experiential learning.
Description of methods: 1. The influence of language and presentation on understanding of test accuracy information is the subject of this research and the authors reference some of the existing work undertaken in this area. However the description of how information was presented to research participants is lacking in important detail. The language used to describe (essentially define) the PPV and the false positive rate in the numerical presentation as well as how participants were asked to express their estimates is an important potential confounder in this comparison. I am unclear why numerical information was presented in the form of the sensitivity and the false positive rate.
Response: As noted in our responses to Reviewers 1 and 2, we have extensively revised the method section to provide clearer descriptions of the numerical and experience formats. We have also provided a new figure (the new Figure 1 ) and an Appendix.
2.This is another potential source of confounding: the numerical presentation describes test performance using test +ve results only whereas the experience presentation presents test positive and test negative outcomes. There is evidence that deriving the probability of disease after a positive test result differs to after a positive result. The values of prevalence and the variation in the sensitivity and specificity of the 3 tests may also affect estimates (for example evidence from the risk communication literature demonstrates that manipulation of small numbers increases difficulty). Independently, the prevalence of the target condition may have had an impact on the difference in accuracy of estimates of PPV and NPV in both groups (for example in the experience format, a low prevalence would have made recall of the denominator (disease positives) easier. What is meant by 'representative' patients? Some more information could be provided in the main body of text but I consider including the questionnaire as an appendix is necessary.
Response: As noted in our responses to Reviewers 1 and 2, we have extensively revised the method section to provide clearer descriptions of the numerical and experience formats. We have also provided a new figure (the new Figure 1 ) and an Appendix. We hope this clarifies the above comment.
Presentation of results:
I am not sure table 1 adds value.
Response: We have removed the table that describes participant information, and have instead added it in-text at the beginning of the results section (p. 7).
The figure would benefit from better labeling (correct PPV and NPV values; numbers in the bars). 4. Abstract, discussion, study limitations: I consider that conclusion are overstated. For example in the abstract tat statement 'experiential exposure significantly improves clinicians PPV and NPV judgements': is not accurate for NPV judgements.
Response: NPV estimates were indeed more accurate in the experience format compared to the numerical format. We now say this more clearly in the abstract and in the results section (ps. 2 and 7).
5. I consider use of the term 'judgement' misleading as this implies using information whereas this study is concerned with understanding information. The impact of understanding about test accuracy on diagnostic judgements is a different question.
Response: We have replaced all mention of "judgments" with the term "estimate".
6. The importance and implications of the results for practice is not clear. There is already a wealth of evidence demonstrating that the use of PVs is intuitive as they convey the probability of disease in an individual rather than the probability of a test result in individuals with or without disease. Also that health professionals' knowledge of test performance is heavily influenced by experience. However because the derivation of PVs is dependent on prevalence the context in which this type of experiential learning takes place is key to its value and accuracy. The notion of fast paced, simulated experience may represent a valuable tool in terms of illustrating the concept of test accuracy but its role in improving knowledge about the performance of tests in use is difficult to imagine.
Response: We have acknowledged that the current results do not reflect subsequent choice nor other clinical outcomes, and suggest this an additional avenue for future research (p. 9). 
GENERAL COMMENTS
The authors have addressed my main concern from my initial review regarding the use of terminology. I have a few more comments that I believe can further strengthen the manuscript.
For unfamiliar readers, the authors should Include in the abstract an example of PPV or NPV or both.
In the first paragraph of the Introduction, the authors state "Overestimation of the PPV, for example, increases the risk of overdiagnosis…". The references refer to risks of overtreatment. Is there any support for the statement that overestimation of the PPV increases the risk of overdiagnosis?
The first sentence on page 5 states that "an experience format increased respondents' understanding of patients' knowledge of the risks and benefits…" To clarify, does it increase respondents' understanding of the risks and benefits, increase patients' knowledge of the risks and benefits, or is the interpretation as it is written?
The last paragraph of page 4 and the first of page 5 could be combined, especially if reference 23 and 24 are part of the "series of studies".
Perhaps the statement "there is significant evidence" is a bit too strong terminology given that only a few studies have been reviewed (first sentence, last paragraph of introduction).
One argument that is not so clear from the Introduction is why the authors anticipate the experience advantage would (or would not) extend to clinicians? The study uses hypothetical scenarios, so it cannot be that clinicians could have pre-existing ideas of PPV or NPV for tests that could influence responses irrespective of format.
Have other studies shown a difference between format effects for experts versus non-experts?
To facilitate understanding of the experimental conditions, Figure 1 could also include the text of one of the problems as presented in the numerical condition rather than having the text in an Appendix. I think this would be important for understanding the type of problem presented in the numerical condition.
Could the authors include a definition of sensitivity and specificity in the Introduction.
Could the authors provide a little more description of the counterbalancing. Each condition (numeric vs. experience x test type) were randomly presented? So participants did not first do the three numeric followed by the three experience tasks (or in a counterbalanced order) but could do any of the 6 problems in any order?
I still think that there is not enough description of the outcome metric used (MAE). The other reviewers also question the use of this metric over others (e.g., percentage correct estimate) and I am not sure this is adequately addressed. Figure 2 now Of 100 individuals with Disease X, eighty four will test positive OR Of every 100 individuals with Disease X eighty four will test +ve with the genetic test 2) Appendix: Although the authors state that participants were requested to present their estimates in a frequency format the appendix does not include the question posed to participants. For example for PPV were participants asked to calculate the PPV / positive predictive value or to calculate the probability of testing positive if they had disease?
Minor: Below are specific further minor comments that I consider would improve readability of the manuscript further. Abstract/Results: "Estimation accuracy was quantified by the mean absolute error (MAE; absolute difference between estimate and true predictive value). PPV estimation errors were higher in the numerical format…" The term 'higher' here could be misinterpreted for 'more positive'. Would 'larger' be clearer?
Introduction:
The authors refer to 'numerical formats' as if they are homogeneous which simplifies important known differences in the way numerical information is provided and interpreted (such as the difference between normalised and natural frequencies). This may result in erroneous conclusions being drawn by readers.
The last paragraph includes the following: "In summary, there is significant evidence suggesting an advantage of experience over numerical formats in the context of diagnostic inference. However, all studies to date have been conducted with medical non-clinicians" Results/Discussion: Generally a statement clarifying the direction and magnitude of estimation of error would be useful here (even if it is conveyed in the figures (I could not access the figures)); in particular the direction of error of estimation for NPV could be clearer (I think it was underestimated therefore lower than the actual value). An emphasis was placed on overestimation of the PPV (as opposed to error of estimation of NPV) the rationale for which I didn't understand. Although the experience format mimics presentation of accuracy in terms of naturally occurring frequencies the extent to which this is discussed could be misleading in the sense it suggests natural frequencies were presented. Please leave your comments for the authors below The authors have addressed my main concern from my initial review regarding the use of terminology. I have a few more comments that I believe can further strengthen the manuscript.
VERSION 2 -AUTHOR RESPONSE
1. For unfamiliar readers, the authors should include in the abstract an example of PPV or NPV or both.
